A bacteriophage journey at the European Medicines Agency-Reference-Cited by-同舟云学术

A bacteriophage journey at the European Medicines Agency

Published:2015-12-10 Issue:2 Volume:363 Page:fnv225
ISSN:1574-6968
Container-title:FEMS Microbiology Letters
language:en
Short-container-title:FEMS Microbiology Letters

Author:

Debarbieux Laurent,Pirnay Jean-Paul,Verbeken Gilbert,De Vos Daniel,Merabishvili Maia,Huys Isabelle,Patey Olivier,Schoonjans Dirk,Vaneechoutte Mario,Zizi Martin,Rohde Christine

Publisher

Oxford University Press (OUP)

Subject

Genetics,Molecular Biology,Microbiology

Link

http://academic.oup.com/femsle/article-pdf/363/2/fnv225/10753806/fnv225.pdf

Reference7 articles.

1. Overcoming global antimicrobial resistance;Carlet,2015

2. Re-establishing a place for phage therapy in western medicine

3. Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

4. Clinical Aspects of Phage Therapy

5. Quality and Safety Requirements for Sustainable Phage Therapy Products

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteriophage therapy- a refurbished age-old potential strategy to treat antibiotic and multidrug resistant bacterial infections in future;Brazilian Journal of Microbiology;2024-07-01

2. Factors of prescribing phage therapy among UK healthcare professionals: Evidence from conjoint experiment and interviews;PLOS ONE;2024-05-07

3. The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation;Viruses;2024-03-12

4. Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series;Antibiotics;2023-12-14

5. Guidelines to Compose an Ideal Bacteriophage Cocktail;Methods in Molecular Biology;2023-12-09